# Ertapenem

NDC: 68001-408
Generic name: Ertapenem Sodium
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20190829

FDA application: ANDA207647

## Active ingredients

- ERTAPENEM SODIUM: 1 g/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-408"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-408
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8eccc96f-4b59-49ee-9997-365a24f59a24